Blood Eosinophils: A Biomarker of Response to Extrafine Beclomethasone/Formoterol in Chronic Obstructive Pulmonary Disease

Am J Respir Crit Care Med. 2015 Aug 15;192(4):523-5. doi: 10.1164/rccm.201502-0235LE.
No abstract available

Publication types

  • Letter
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic beta-2 Receptor Agonists / therapeutic use*
  • Beclomethasone / therapeutic use*
  • Biomarkers / blood
  • Double-Blind Method
  • Drug Therapy, Combination
  • Eosinophils
  • Ethanolamines / therapeutic use*
  • Formoterol Fumarate
  • Glucocorticoids / therapeutic use*
  • Humans
  • Leukocyte Count
  • Pulmonary Disease, Chronic Obstructive / blood*
  • Pulmonary Disease, Chronic Obstructive / complications
  • Pulmonary Disease, Chronic Obstructive / drug therapy*
  • Treatment Outcome

Substances

  • Adrenergic beta-2 Receptor Agonists
  • Biomarkers
  • Ethanolamines
  • Glucocorticoids
  • Beclomethasone
  • Formoterol Fumarate